首页>
外文期刊>International Pharmaceutical Quality
>Recent Technology and Partnership Advances Made Possible Precision and Speed of Vaccine Response to Pandemic, NIAID's Graham Stresses at CASSS WCBP Conference
【24h】
Recent Technology and Partnership Advances Made Possible Precision and Speed of Vaccine Response to Pandemic, NIAID's Graham Stresses at CASSS WCBP Conference
The precision and speed of COVID-19 vaccine development was made possible by recent R&D advancements and a strengthened network of public-private partnerships, NIH National Institute for Allergy and Infectious Diseases (MAID) Vaccine Research Center (VCR) Deputy Director Barney Graham affirmed in his keynote presentation at the opening session of the CASSS Well-Characterized Biotechnology Products (WCBP) conference in late January. Building on the foundation of these more robust technologies and partnerships, he explained, "we ended up with a good result - even better than we had hoped." The COVID experience and learnings, in turn, Graham emphasized, suggest that "prototype pathogen preparedness is feasible, even for the other viral families that remain out there" where vaccine development has not yet matured.
展开▼
